269 related articles for article (PubMed ID: 37754852)
41. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
[TBL] [Abstract][Full Text] [Related]
42. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and characterization of acetyl curcumin-loaded core/shell liposome nanoparticles via an electrospray process for drug delivery, and theranostic applications.
Reddy AS; Lakshmi BA; Kim S; Kim J
Eur J Pharm Biopharm; 2019 Sep; 142():518-530. PubMed ID: 31365879
[TBL] [Abstract][Full Text] [Related]
44. Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development.
Mehta M; Bui TA; Yang X; Aksoy Y; Goldys EM; Deng W
ACS Mater Au; 2023 Nov; 3(6):600-619. PubMed ID: 38089666
[TBL] [Abstract][Full Text] [Related]
45. Core-Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems.
Mehandole A; Walke N; Mahajan S; Aalhate M; Maji I; Gupta U; Mehra NK; Singh PK
AAPS PharmSciTech; 2023 Jan; 24(1):50. PubMed ID: 36703085
[TBL] [Abstract][Full Text] [Related]
46. Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery.
Dehaini D; Fang RH; Luk BT; Pang Z; Hu CM; Kroll AV; Yu CL; Gao W; Zhang L
Nanoscale; 2016 Aug; 8(30):14411-9. PubMed ID: 27411852
[TBL] [Abstract][Full Text] [Related]
47. Design and production of hybrid nanoparticles with polymeric-lipid shell-core structures: conventional and next-generation approaches.
Bochicchio S; Dalmoro A; Bertoncin P; Lamberti G; Moustafine RI; Barba AA
RSC Adv; 2018 Oct; 8(60):34614-34624. PubMed ID: 35548606
[TBL] [Abstract][Full Text] [Related]
48. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Liu Y; Li K; Pan J; Liu B; Feng SS
Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
[TBL] [Abstract][Full Text] [Related]
49. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.
Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA
Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666
[No Abstract] [Full Text] [Related]
50. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications.
Jose C; Amra K; Bhavsar C; Momin M; Omri A
Crit Rev Ther Drug Carrier Syst; 2018; 35(6):555-588. PubMed ID: 30317969
[TBL] [Abstract][Full Text] [Related]
51. Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl
Abdou EM; Fayed MAA; Helal D; Ahmed KA
Sci Rep; 2019 Dec; 9(1):19779. PubMed ID: 31875004
[TBL] [Abstract][Full Text] [Related]
52. Biomimetic synthesis of raspberry-like hybrid polymer-silica core-shell nanoparticles by templating colloidal particles with hairy polyamine shell.
Pi M; Yang T; Yuan J; Fujii S; Kakigi Y; Nakamura Y; Cheng S
Colloids Surf B Biointerfaces; 2010 Jul; 78(2):193-9. PubMed ID: 20347275
[TBL] [Abstract][Full Text] [Related]
53. Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.
Ali S; Amin MU; Tariq I; Sohail MF; Ali MY; Preis E; Ambreen G; Pinnapireddy SR; Jedelská J; Schäfer J; Bakowsky U
Int J Nanomedicine; 2021; 16():951-976. PubMed ID: 33603362
[TBL] [Abstract][Full Text] [Related]
54. Polymeric Core-Shell Nanoparticles Prepared by Spontaneous Emulsification Solvent Evaporation and Functionalized by the Layer-by-Layer Method.
Szczęch M; Szczepanowicz K
Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32164194
[TBL] [Abstract][Full Text] [Related]
55. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
56. Formulation of Piperine Nanoparticles: In Vitro Breast Cancer Cell Line and In Vivo Evaluation.
Kazmi I; Al-Abbasi FA; Imam SS; Afzal M; Nadeem MS; Altayb HN; Alshehri S
Polymers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406223
[TBL] [Abstract][Full Text] [Related]
57. A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs.
Li Q; Cai T; Huang Y; Xia X; Cole SPC; Cai Y
Nanomaterials (Basel); 2017 May; 7(6):. PubMed ID: 28554993
[TBL] [Abstract][Full Text] [Related]
58. Lipid Nanoparticles-Encapsulated YF4: A Potential Therapeutic Oral Peptide Delivery System for Hypertension Treatment.
Zhao S; Li J; Zhou Y; Huang L; Li Y; Xu J; Fu C; Guo X; Yang J
Front Pharmacol; 2019; 10():102. PubMed ID: 30873021
[TBL] [Abstract][Full Text] [Related]
59. Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.
Yang Z; Luo X; Zhang X; Liu J; Jiang Q
Biomed Mater; 2013 Apr; 8(2):025012. PubMed ID: 23507576
[TBL] [Abstract][Full Text] [Related]
60. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
